| Literature DB >> 339986 |
G D Chisholm, E P O'Donoghue, C L Kennedy.
Abstract
30 patients with oestrogen-escaped carcinoma of the prostate have been treated with estramustine phosphate (Estracyt). 27% showed a partial objective response and 33% had a subjective response. The terms used for defining a response are challenged and it is recommended that comparative controlled trials are necessary to judge the place of this drug in the management of advanced prostatic cancer.Entities:
Mesh：
Substances：
Year: 1977 PMID： 339986 DOI： 10.1111/j.1464-410x.1977.tb04559.x
Source DB: PubMed Journal: Br J Urol ISSN： 0007-1331